Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...
SAN FRANCISCO—Despite ongoing worries about the strength of the economy, a new report on U.S. advertising in the first half of 2025 by Samba TV indicates that large TV advertisers were continuing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback